The Prognostic Significance of Epidermal Growth Factor Receptor Amplification and Epidermal Growth Factor Receptor Variant III Mutation in Glioblastoma: A Systematic Review and Meta-Analysis with Implications for Targeted Therapy. [PDF]
Zhu F, Qiu J, Ye H, Su W, Wang R, Fu Y.
europepmc +1 more source
Human Epidermal Growth Factor Receptor 2-Low Breast Cancer: Prevalence Rate and Scoring Concordance Among Pathologists. [PDF]
Sughayer M+5 more
europepmc +1 more source
A momentous progress update: epidermal growth factor receptor inhibitors as viable agents for combating cancer. [PDF]
Jangra N, Sharma B, Kumar D, Kapoor A.
europepmc +1 more source
Predicting Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer Based on Radiomics of MRI Habitat and US. [PDF]
Lin Z, Huang F, Wei L, Liao X, Gao Y.
europepmc +1 more source
The Role of Fibroblast Growth Factor Receptor 2 as A Prognostic Biomarker in Colorectal Adenocarcinoma. [PDF]
Rianti AM+5 more
europepmc +1 more source
A prognostic signature for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. [PDF]
Liu Y+12 more
europepmc +1 more source
Growth factor receptor plasticity drives therapeutic persistence of metastatic breast cancer. [PDF]
Ayers M+6 more
europepmc +1 more source